Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol
about
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem CellsReport from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell ReplacementInflammatory response in islet transplantation.Insulin sensitivity index in type 1 diabetes and following human islet transplantation: comparison of the minimal model to euglycemic clamp measures.Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop.Assessment of β-cell mass and α- and β-cell survival and function by arginine stimulation in human autologous islet recipients.Pancreatic ductal perfusion at organ procurement enhances islet yield in human islet isolation.Restoration of Glucose Counterregulation by Islet Transplantation in Long-standing Type 1 DiabetesIslet transplantation for type 1 diabetes, 2015: what have we learned from alloislet and autoislet successes?Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop.Successful Application of Closed-Loop Artificial Pancreas Therapy After Islet Autotransplantation.Puzzling about partial glucagon responses to hypoglycemia in intrahepatic islet recipients: missing pieces.Validation of the BETA-2 Score: An Improved Tool to Estimate Beta Cell Function After Clinical Islet Transplantation Using a Single Fasting Blood Sample.Minimizing immunosuppression in islet xenotransplantation.Clinical implementation of islet transplantation: A current assessment.Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.Islet cell transplant: Update on current clinical trials.Brief review: cell replacement therapies to treat type 1 diabetes mellitus.Long-Term Improvement in Glucose Control and Counterregulation by Islet Transplantation for Type 1 Diabetes.Positron Emission Tomography to Assess the Outcome of Intraportal Islet Transplantation.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Multicenter Assessment of Animal-free Collagenase AF-1 for Human Islet Isolation.Cost and clinical outcome of islet transplantation in Norway 2010-2015.Unmethylated Insulin DNA Is Elevated After Total Pancreatectomy With Islet Autotransplantation: Assessment of a Novel Beta Cell Marker.Loss of end-differentiated β-cell phenotype following pancreatic islet transplantation.Defining Outcomes for β-Cell Replacement Therapy in the Treatment of Diabetes: a Consensus Report on the Igls Criteria from the IPITA/EPITA Opinion Leaders Workshop.α-1 Antitrypsin Enhances Islet Engraftment by Suppression of Instant Blood-Mediated Inflammatory Reaction.
P2860
Q26752205-F8A213DA-D367-429A-AC41-319B6765EDCBQ26769878-7C1D92E1-EFE6-4830-96CD-00EF96A52F05Q33614652-52F74A52-D1A2-41AE-935E-637C7E2B574FQ33628076-C1834C51-27D9-4DB9-93F1-FA825130AB45Q34383031-BED54864-F6DD-478B-885D-34EDA692A8E6Q35004304-9D38D3A2-7E54-498A-BC69-4740D47E090DQ35410997-D8B5056C-1E85-4252-B66C-B632EE4808D3Q35532258-88320643-A74D-4C11-AF48-EE3364580B5DQ35630705-48F6B531-1213-4D95-AF5A-6E919D5BEC49Q35630711-49D648E9-7009-47B9-82AB-3B4AFDB14C63Q36054574-6E76B22E-9F12-4FEB-8A35-EA20B2B340FDQ36834244-9AFDBE1B-B601-47C2-895F-8D87F2ACDAECQ36926310-699EA0E5-BC27-4E8C-B5FC-B67630EAEC7BQ37357372-D9C71A52-36C7-44E1-8665-40AAFB5F72F2Q38210810-65B311DA-AB87-4A49-86AE-5A0B711408ACQ38530484-948B0E3B-063E-4616-A4F8-7966369FD6D0Q38651610-13CA1D64-5BF6-4C96-BAFA-A08A833C482FQ38689971-C3A567DA-C084-4DD4-BC51-0B8AE1C61CC2Q39431694-803302AB-7ED5-43AA-9ADA-A93A0F4C93ECQ39444068-C6E1C01B-95EB-4ED8-9E86-2E12B2143011Q40955221-D7E924C4-6437-44F0-935E-C821581CB664Q47155255-FA87F50C-CA4E-45CC-B068-3F93F9D9F5A3Q47292885-7096C436-B269-4877-8FAB-E936F332A579Q47628461-4ED3E4F3-9EB8-43F7-B6A6-442774AB7E31Q48282844-474D779D-8BD5-4D67-A674-C93722209406Q49832092-71C40BB9-E1DF-4F27-A605-024603652AE9Q49906467-776C2932-FA1A-4E84-8E6A-9A055DB11E04Q51204217-A88D3DB2-87AB-499D-A4DC-A8F210414CD7
P2860
Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Improvement in β-cell secretor ...... ccording to the CIT07 protocol
@en
Improvement in β-cell secretor ...... cording to the CIT07 protocol.
@nl
type
label
Improvement in β-cell secretor ...... ccording to the CIT07 protocol
@en
Improvement in β-cell secretor ...... cording to the CIT07 protocol.
@nl
prefLabel
Improvement in β-cell secretor ...... ccording to the CIT07 protocol
@en
Improvement in β-cell secretor ...... cording to the CIT07 protocol.
@nl
P2093
P2860
P356
P1433
P1476
Improvement in β-cell secretor ...... ccording to the CIT07 protocol
@en
P2093
Allen J Chiou
Carissa Fuller
Chengyang Liu
Clyde F Barker
Cornelia Dalton-Bakes
Eileen Markmann
Eline T Luning Prak
Kumar Vivek
Malek Kamoun
P2860
P304
P356
10.2337/DB12-1802
P407
P577
2013-04-29T00:00:00Z